Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page now states that the study is no longer enrolling participants, with a minor formatting adjustment to the Intervention/Treatment heading.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a small version update without visible changes to the page content.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded related topic tags for Rheumatoid arthritis and MedlinePlus Genetics to the page's metadata. Updated the site revision from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThese updates reflect a small normalization of a listed location spelling (Ādaži → Adazi) and a non-clinical update to the ClinicalTrials.gov page software revision (v3.5.2 → v3.5.3).SummaryDifference0.0%

- Check69 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics and updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check76 days agoChange DetectedRheumatoid arthritis and related topics: MedlinePlus Genetics were removed from the page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.